193 related articles for article (PubMed ID: 9638402)
1. The interaction of alcoholic liver disease and hepatitis C.
Marsano LS; Peña LR
Hepatogastroenterology; 1998; 45(20):331-9. PubMed ID: 9638402
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of alcoholic liver disease with HCV].
Tsutsumi M; Takase S
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):649-53. PubMed ID: 15359878
[No Abstract] [Full Text] [Related]
3. National survey of hepatocellular carcinoma in heavy drinkers in Japan.
Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Shiomi S; Kinoshita H
Gan To Kagaku Ryoho; 2001 Dec; 28(13):1975-9. PubMed ID: 11791377
[TBL] [Abstract][Full Text] [Related]
5. [Liver diseases caused by alcohol consumption and hepatitis C virus infection: association, addition or potentiation?].
Alscher DM; Bode JC
Dtsch Med Wochenschr; 2001 Feb; 126(5):117-22. PubMed ID: 11225387
[No Abstract] [Full Text] [Related]
6. [Steatosis and hepatitis C].
Testino G
Recenti Prog Med; 2005 Dec; 96(12):621-33; quiz 654. PubMed ID: 16496750
[TBL] [Abstract][Full Text] [Related]
7. Alcohol and viral hepatitis: a mini-review.
Gitto S; Micco L; Conti F; Andreone P; Bernardi M
Dig Liver Dis; 2009 Jan; 41(1):67-70. PubMed ID: 18602355
[TBL] [Abstract][Full Text] [Related]
8. [Treatment for alcoholic liver disease with HCV].
Tsutsumi M; Takada A
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):866-70. PubMed ID: 7563892
[No Abstract] [Full Text] [Related]
9. Review article: nonalcoholic fatty liver disease and hepatitis C virus--partners in crime.
Blonsky JJ; Harrison SA
Aliment Pharmacol Ther; 2008 May; 27(10):855-65. PubMed ID: 18315584
[TBL] [Abstract][Full Text] [Related]
10. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
Horie Y; Yamagishi Y; Ishii H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
[TBL] [Abstract][Full Text] [Related]
11. Alcohol and hepatitis C.
Safdar K; Schiff ER
Semin Liver Dis; 2004 Aug; 24(3):305-15. PubMed ID: 15349807
[TBL] [Abstract][Full Text] [Related]
12. [Incidence of hepatocellular carcinoma in patients treated with interferon].
Yokosuka O; Omata M
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):805-9. PubMed ID: 7563880
[No Abstract] [Full Text] [Related]
13. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.
Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
J Gastroenterol; 2005 Feb; 40(2):148-56. PubMed ID: 15770398
[TBL] [Abstract][Full Text] [Related]
14. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
Yoshida H; Omata M
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
[No Abstract] [Full Text] [Related]
15. [Risk factors of liver tumors].
Fehér J; Lengyel G
Orv Hetil; 2004 Feb; 145(7 Suppl 1):365-7. PubMed ID: 15049052
[TBL] [Abstract][Full Text] [Related]
16. [Hepatitis C and alcohol].
Perlemuter G
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
[No Abstract] [Full Text] [Related]
17. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
[TBL] [Abstract][Full Text] [Related]
18. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
[TBL] [Abstract][Full Text] [Related]
19. Development of hepatocellular carcinoma after sustained response to interferon therapy: how long should sustained responders with risk factors be followed?
Kasahara A
J Gastroenterol; 2005 Feb; 40(2):220-2. PubMed ID: 15770412
[No Abstract] [Full Text] [Related]
20. The natural history of hepatitis C viral infection.
Muir AJ
Semin Gastrointest Dis; 2000 Apr; 11(2):54-61. PubMed ID: 10803630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
